SCHEDULE 13G/A: Aaron Rollins Discloses 25% Stake in Airsculpt Technologies, Inc.
Beneficial Ownership Disclosure
Dr. Aaron Rollins, an individual, has reported beneficial ownership of 25.0% of Airsculpt Technologies, Inc.'s common stock as of March 31, 2025.
Summary
- Aaron Rollins, the reporting person, beneficially owns 14,718,944 shares of Airsculpt Technologies, Inc. common stock.
- This ownership represents 25.0% of the Issuer's outstanding common stock.
- The percentage is calculated based on 58,779,850 shares of common stock outstanding as of May 1, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q filed on May 2, 2025.
- Dr. Rollins holds sole voting power and sole dispositive power over all 14,718,944 shares.
- The filing is an Amendment No. 5 to a Schedule 13G, indicating a change in previously reported beneficial ownership.
Sentiment
Score: 6
Explanation: The filing is a factual disclosure of beneficial ownership. The maintenance of a significant stake by a key individual like Dr. Rollins could be viewed as a positive signal of confidence, though the document itself is neutral in tone.
Positives
- The maintenance of a significant 25.0% stake by Dr. Aaron Rollins, a key individual, may signal continued confidence in Airsculpt Technologies, Inc.'s future prospects.
Future Outlook
This Schedule 13G filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This filing is a standard regulatory disclosure of a significant ownership stake by an individual in a publicly traded company. It does not provide specific insights into broader industry trends or competitive landscape, but rather focuses on the ownership structure of Airsculpt Technologies, Inc.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant ownership stakes, which can influence investor perception and potentially the company's strategic direction due to a large individual holder.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which requires the filing of this statement (beneficial ownership calculation date). |
| 05/01/2025 | Date as of which 58,779,850 shares of Common Stock outstanding were reported in the Issuer's Form 10-Q. |
| 05/02/2025 | Date the Issuer's Quarterly Report on Form 10-Q for the period ended March 31, 2025, was filed with the SEC. |
| 05/13/2025 | Date this Schedule 13G Amendment No. 5 was signed and filed. |
Keywords
Airsculpt Technologies, Aaron Rollins, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Ownership Disclosure
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.